PMID- 31882773 OWN - NLM STAT- MEDLINE DCOM- 20201207 LR - 20210110 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 9 IP - 1 DP - 2019 Dec 27 TI - Database of adverse events associated with drugs and drug combinations. PG - 20025 LID - 10.1038/s41598-019-56525-5 [doi] LID - 20025 AB - Due to the aging world population and increasing trend in clinical practice to treat patients with multiple drugs, adverse events (AEs) are becoming a major challenge in drug discovery and public health. In particular, identifying AEs caused by drug combinations remains a challenging task. Clinical trials typically focus on individual drugs rather than drug combinations and animal models are unreliable. An added difficulty is the combinatorial explosion in the number of possible combinations that can be made using the increasingly large set of FDA approved chemicals. We present a statistical and computational technique for identifying AEs caused by two-drug combinations. Taking advantage of the large and increasing data deposited in FDA's postmarketing reports, we demonstrate that the task of predicting AEs for 2-drug combinations is amenable to the Likelihood Ratio Test (LRT). Our pAERS database constructed with LRT contains almost 77 thousand associations between pairs of drugs and corresponding AEs caused solely by drug-drug interactions (DDIs). The DDIs stored in pAERS complement the existing data sets. Due to our stringent statistical test, we expect many of the associations in pAERS to be unrecorded or poorly documented in the literature. FAU - Poleksic, Aleksandar AU - Poleksic A AD - Department of Computer Science, University of Northern Iowa, Cedar Falls, Iowa, 50614, USA. poleksic@cs.uni.edu. FAU - Xie, Lei AU - Xie L AUID- ORCID: 0000-0001-9051-2111 AD - Department of Computer Science, Hunter College, The City University of New York, New York, New York, 10065, USA. lxie@iscb.org. AD - Ph.D. Program in Computer Science, Biochemistry and Biology, The Graduate Center, The City University of New York, New York, New York, 10065, USA. lxie@iscb.org. LA - eng GR - R01 AG057555/AG/NIA NIH HHS/United States GR - R01 GM122845/GM/NIGMS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20191227 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Drug Combinations) SB - IM MH - *Adverse Drug Reaction Reporting Systems MH - *Databases, Factual MH - *Drug Combinations MH - Humans MH - United States PMC - PMC6934730 COIS- The authors have no competing interests as defined by Nature Research, or other interests that might be perceived to influence the results and/or discussion reported in this paper. EDAT- 2019/12/29 06:00 MHDA- 2020/12/15 06:00 PMCR- 2019/12/27 CRDT- 2019/12/29 06:00 PHST- 2019/04/09 00:00 [received] PHST- 2019/12/13 00:00 [accepted] PHST- 2019/12/29 06:00 [entrez] PHST- 2019/12/29 06:00 [pubmed] PHST- 2020/12/15 06:00 [medline] PHST- 2019/12/27 00:00 [pmc-release] AID - 10.1038/s41598-019-56525-5 [pii] AID - 56525 [pii] AID - 10.1038/s41598-019-56525-5 [doi] PST - epublish SO - Sci Rep. 2019 Dec 27;9(1):20025. doi: 10.1038/s41598-019-56525-5.